The efficacy and safety of bevacizumab in addition to platinum-based chemotherapy for the first-line treatment of patients with advanced nonsquamous non-small-cell lung cancer: Final results of AVALANCHE, an observational cohort study.

Oncol Lett · 2019 · PMC6341671 · PMID 30675234

Europe PMC DOI

hedged sentence

0.0710

closest p · 1.4× alpha

0.0710

boldest claim

The sentences

on the boundary of significanceP=0.071so close (0.05 < p ≤ 0.1)

Women had longer PFS and OS than men in the AVALANCHE, however, only OS was on the boundary of significance (P=0.071).

also in 20 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.